XML 81 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Current and Deferred Tax Provision

A summary of the Company’s current and deferred tax provision is as follows:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Current income tax expense (benefit):

 

 

 

 

 

 

 

 

Federal

 

$

-

 

 

$

-

 

State

 

 

17

 

 

 

17

 

Total current income tax expense (benefit)

 

 

17

 

 

 

17

 

Deferred income tax expense (benefit):

 

 

 

 

 

 

 

 

Federal

 

 

1

 

 

 

(2,366

)

State

 

 

2

 

 

 

(2,351

)

Total deferred tax expense (benefit)

 

 

3

 

 

 

(4,717

)

Total (benefit) from income taxes

 

$

20

 

 

$

(4,700

)

Schedule of Reconciliation of the U.S. Federal Statutory Income Tax

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Federal statutory income tax rate

 

 

21.0

%

 

 

21.0

%

State income taxes, net of federal benefits

 

 

9.8

%

 

 

3.0

%

Research and development tax credits

 

 

1.5

%

 

 

1.0

%

Interest accretion expense

 

 

8.6

%

 

 

5.5

%

Change in valuation allowance

 

 

(46.1

)%

 

 

(21.6

)%

Mark to market warrant

 

 

2.8

%

 

 

(5.7

)%

Other permanent items

 

 

2.4

%

 

 

(1.0

)%

Effective income tax rate

 

 

0.0

%

 

 

2.2

%

Schedule of Net Deferred Tax Liabilities

Net deferred tax liabilities as of years ended December 31, 2021 and 2020 consisted of the following:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

88,327

 

 

$

53,495

 

Research and development tax credit carryforwards

 

 

7,672

 

 

 

5,673

 

Stock-based compensation expense

 

 

11,748

 

 

 

1,304

 

Startup costs

 

 

697

 

 

 

729

 

Intangible assets

 

 

4,471

 

 

 

4,544

 

Deferred revenue

 

 

1,103

 

 

 

3,226

 

Unicap

 

 

6

 

 

 

6

 

Imputed interest on contingent payments

 

 

4,410

 

 

 

2,340

 

Legal fee capitalization and amortization

 

 

1,550

 

 

 

1,587

 

Other

 

 

1,535

 

 

 

1,158

 

Total deferred tax assets

 

 

121,519

 

 

 

74,062

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

In-process research and development

 

 

(29,232

)

 

 

(27,930

)

Total deferred tax liabilities

 

 

(29,232

)

 

 

(27,930

)

Valuation allowance

 

 

(92,297

)

 

 

(46,139

)

Net deferred tax liabilities

 

$

(10

)

 

$

(7

)

Schedule of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 

 

 

Unrecognized

Tax Benefits

 

Balance at December 31, 2019

 

$

786

 

Increase related to current year tax provisions

 

 

242

 

Balance at December 31, 2020

 

$

1,028

 

Increase related to current year tax provisions

 

 

242

 

Balance at December 31, 2021

 

$

1,270